These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1359908)

  • 1. Synthesis and beta-adrenergic antagonist activity of novel (3-oxazolinyl-1,4-dihydropyridyl) propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1992 Jul; 8(4):265-72. PubMed ID: 1359908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and cardioselective beta-adrenergic antagonist activity of quinolyloxypropanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1992; 9(1):69-78. PubMed ID: 1360842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and adrenergic beta-blocking activity of ortho-, meta- and para-oxypropanolamino-substituted [(benzylideneamino)oxy]propanolamines.
    Balsamo A; Lapucci A; Macchia B; Macchia M; Orlandini E; Rossello A; Ferni G; Pinza M
    Farmaco; 1995 Apr; 50(4):239-43. PubMed ID: 7669168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. beta-Adrenergic blocking agents. alpha- and gamma-methyl(aryloxy)propanolamines.
    Lemke TL; Cramer MB; Adamski SW; Pedone CA; Brooker G
    J Med Chem; 1981 Oct; 24(10):1211-4. PubMed ID: 6120233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and beta-adrenergic activity of new completely aliphatic 3-(methyleneaminoxy)propanolamine derivatives.
    Balsamo A; Gentili D; Lapucci A; Macchia M; Martinelli A; Orlandini E; Ferni G; Pinza M
    Farmaco; 1994 Dec; 49(12):759-66. PubMed ID: 7893332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioselective beta-adrenergic blocking agents. 1. 1-((3,4-Dimethoxyphenethyl)amino)-3-aryloxy-2-propanols.
    Hoefle ML; Hastings SG; Meyer RF; Corey RM; Holmes A; Stratton CD
    J Med Chem; 1975 Feb; 18(2):148-52. PubMed ID: 235644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivatives related to betaxolol with alpha- and beta-adrenergic activities.
    Leclerc G; Decker N; Schwartz J
    Arzneimittelforschung; 1985; 35(9):1357-67. PubMed ID: 2867769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-activity relationships. Fujita-Ban analysis of beta-adrenergic blocking activity of 1-phenoxy-3-([(substituted amido)alkyl]amino)-2-propanols.
    Gombar V
    Arzneimittelforschung; 1986 Jul; 36(7):1014-8. PubMed ID: 2876713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the synthesis of compounds with beta-adrenergic activity (author's transl)].
    Lehmann D; Eckardt R; Faust G; Fiedler W
    Pharmazie; 1980; 34(5-6):278-84. PubMed ID: 6106206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nondepressant beta-adrenergic blocking agents. 1. Substituted 3-amino-1-(5,6,7,8-tetrahydro-1-naphthoxy)-2-propanols.
    Condon ME; Cimarusti CM; Fox R; Narayanan VL; Reid J; Sundeen JE; Hauck FP
    J Med Chem; 1978 Sep; 21(9):913-22. PubMed ID: 31485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adrenergic beta receptor blockaders. IV. 1-(Hydroxy- or dihydroxyphenoxy)-3-isopropylamino-2-propanols].
    Casagrande C; Ferrini R; Miragoli G; Ferrari G
    Boll Chim Farm; 1973 Jul; 112(7):445-54. PubMed ID: 4148774
    [No Abstract]   [Full Text] [Related]  

  • 15. [Synthesis of 2-{3-[4-(4-fluorophenyl)-1-piperazinyl]-2-hydroxy-propoxy}-phenylcarbamic acid alkylesters and in vitro evaluation of their beta-antiadrenergic and vasodilatative activities].
    Gonec T; Racanská E; Csöllei J
    Ceska Slov Farm; 2008 Jun; 57(3):115-8. PubMed ID: 18683428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function.
    Erhardt PW; Woo CM; Anderson WG; Gorczynski RJ
    J Med Chem; 1982 Dec; 25(12):1408-12. PubMed ID: 6130154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic blocking agents: substituted phenylalkanolamines. Effect of side-chain length on beta-blocking potency in vitro.
    Fuhrer W; Ostermayer F; Zimmermann M; Meier M; Müller H
    J Med Chem; 1984 Jul; 27(7):831-6. PubMed ID: 6145802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.
    Cecchetti V; Fravolini A; Fringuelli R; Schiaffella F; Mascellani G; Pagella PG; Rugarli PL
    Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [(Arylcarbonyl)oxy]propanolamines. 1. Novel beta-blockers with ultrashort duration of action.
    Kam ST; Matier WL; Mai KX; Barcelon-Yang C; Borgman RJ; O'Donnell JP; Stampfli HF; Sum CY; Anderson WG; Gorczynski RJ
    J Med Chem; 1984 Aug; 27(8):1007-16. PubMed ID: 6146718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxic activity of (E)-1-(2-nitrovinyl) and 1-[N-(tert-butylformiminyl)]-substituted 1,4-dihydropyridines and 2-pyridones.
    Im C; Knaus EE; Thuynsma RP; Allen TM
    Drug Des Deliv; 1990 Mar; 5(3):239-48. PubMed ID: 1670504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.